Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b19031013097854c23d455965fc5b206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe2d8a10ec14cd3998ef9c0637e811b1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 |
filingDate |
2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f27b78ecfe1e1246a01bd011c699fd |
publicationDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018091637-A1 |
titleOfInvention |
Probiotic yeasts as novel vaccination vectors |
abstract |
The present invention refers to an immunotherapeutic composition comprising a probiotic yeast vehicle and a fusion protein or a protein comprising at least one HIV antigen and uses thereof. In particular the composition is for the treatment of human immunodeficiency virus (HIV) infection or in the treatment of at least one symptom resulting from HIV infection. The present invention also relates to a method to prepare said immunotherapeutic composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114269374-A |
priorityDate |
2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |